MISP and gastric cancer: In summary, our findings revealed that MISP was overexpressed in over 80% of GC cases, exhibiting strong expression in IM, where it was associated with the expression of MUC2 and CDX2, indicating a close association with an intestinal phenotype in gastric carcinogenesis.